Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07531628
PHASE1

A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

To assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.

Official title: Pharmacokinetics, Safety, and Tolerability Study of Multiple Oral Doses of Verducatib for 4 Weeks in Healthy Chinese Male and Female Trial Participants (Open-label, Single Arm)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2026-07-13

Completion Date

2026-10-14

Last Updated

2026-04-15

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Verducatib

Verducatib

Locations (1)

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, China